ADME pharmacogenetics: investigation of the pharmacokinetics of the antiretroviral agent lopinavir coformulated with ritonavir

Lubomirov, Rubin; di Iulio, Julia; Fayet, Aurélie; Colombo, Sara; Martinez, Raquel; Marzolini, Catia; Furrer, Hansjakob; Vernazza, Pietro; Calmy, Alexandra; Cavassini, Matthias; Ledergerber, Bruno; Rentsch, Katharina; Descombes, Patrick; Buclin, Thierry; Decosterd, Laurent A; Csajka, Chantal; Telenti, Amalio; Swiss HIV Cohort Study, (2010). ADME pharmacogenetics: investigation of the pharmacokinetics of the antiretroviral agent lopinavir coformulated with ritonavir. Pharmacogenetics and genomics, 20(4), pp. 217-30. London: Lippincott Williams & Wilkins 10.1097/FPC.0b013e328336eee4

Full text not available from this repository. (Request a copy)

An ADME (absorption, distribution, metabolism and excretion)-pharmacogenetics association study may identify functional variants relevant to the pharmacokinetics of lopinavir co-formulated with ritonavir (LPV/r), a first-line anti-HIV agent.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Infectiology

UniBE Contributor:

Furrer, Hansjakob

ISSN:

1744-6872

Publisher:

Lippincott Williams & Wilkins

Language:

English

Submitter:

Factscience Import

Date Deposited:

04 Oct 2013 14:12

Last Modified:

17 Mar 2015 19:15

Publisher DOI:

10.1097/FPC.0b013e328336eee4

PubMed ID:

20139798

Web of Science ID:

000276373800001

URI:

https://boris.unibe.ch/id/eprint/2706 (FactScience: 205573)

Actions (login required)

Edit item Edit item
Provide Feedback